Name: Pharming Group N.V. (PHAR) Balance Sheet
Creator: FinSpry

Pharming Group Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Pharming Group N.V. (PHAR) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	54.94	213.42	207.34	8.65	7.12	66.30	80.31
Short-Term Investments	112.95	151.68	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	167.89	213.42	207.34	8.65	7.12	66.30	80.31
Accounts Receivable	41.53	42.62	25.33	30.00	35.90	23.46	16.00
Inventory	55.72	56.76	42.33	27.30	21.16	14.47	17.32
Other Current Assets	4.65	3.54	2.29	2.39	4.02	0.00	0.00
Total Current Assets	278.44	316.34	277.50	249.44	263.21	106.50	115.44
Non-Current Assets
Property, Plant & Equipment (Net)	24.13	33.47	39.15	33.17	21.65	14.53	8.40
Long-Term Investments	0.47	10.40	9.73	8.65	7.12	0.00	0.00
Intangible Assets	61.04	71.27	74.87	83.57	88.63	0.00	0.00
Other Non-Current Assets	1.51	1.53	1.33	0.81	0.51	2.27	1.20
Total Non-Current Assets	121.55	146.51	148.30	147.87	155.24	121.71	99.04
Total Assets	399.99	462.85	425.80	397.32	418.45	228.21	214.48
Current Liabilities
Accounts Payable	10.10	72.53	8.75	42.47	47.67	36.25	28.59
Short-Term Debt	4.25	1.82	1.77	1.88	2.04	0.00	0.00
Current Portion of Long-Term Debt	4.25	1.82	1.77	1.88	2.04	0.00	0.00
Accrued Liabilities	53.22	50.27	43.61	33.34	33.40	0.00	0.00
Other Current Liabilities	53.22	0.00	22.97	21.22	56.88	18.10	17.71
Total Current Liabilities	73.80	77.97	59.70	46.77	76.85	101.89	82.60
Non-Current Liabilities
Long-Term Debt	78.15	166.11	131.62	157.46	157.96	4.36	37.43
Other Non-Current Liabilities	0.00	0.00	-1.23	7.59	7.52	17.28	32.03
Total Non-Current Liabilities	105.12	166.11	161.46	157.63	158.17	21.65	70.13
Total Liabilities	178.92	244.07	221.16	233.04	274.21	123.53	152.73
Stockholders' Equity
Common Stock	7.77	7.67	7.51	7.43	7.31	0.00	0.00
Retained Earnings	-275.49	-265.26	-265.17	-273.17	-295.62	-297.62	-333.64
Accumulated Other Comprehensive Income	-0.21	-2.06	-8.74	3.40	24.61	3.72	1.65
Additional Paid-in Capital	488.99	478.43	462.30	455.25	447.13	392.27	387.53
Shares Outstanding	680.31	671.07	656.35	648.75	0.00	0.00	0.00
Total Stockholders' Equity	221.06	218.78	204.64	192.92	183.44	104.68	61.75
Total Liabilities & Equity	399.99	462.85	425.80	397.32	418.45	228.21	214.48